These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 765496

  • 41. Immunological studies on urinary bladder tumors of rats and mice.
    Taranger LA, Chapman WH, Hellström I, Hellström KE.
    Science; 1972 Jun 23; 176(4041):1337-40. PubMed ID: 5034547
    [Abstract] [Full Text] [Related]

  • 42. BCG immunotherapy of bladder cancer: inhibition of tumor recurrence and associated immune responses.
    Lamm DL, Thor DE, Winters WD, Stogdill VD, Radwin HM.
    Cancer; 1981 Jul 01; 48(1):82-8. PubMed ID: 7016300
    [Abstract] [Full Text] [Related]

  • 43. [Lymphocytes. Roles in cellular immunity and humoral immunity].
    Golovtchenko AM, Raichvarg D.
    Ann Biol Clin (Paris); 1975 Jul 01; 33(2):63-74. PubMed ID: 1080972
    [Abstract] [Full Text] [Related]

  • 44. The interaction of host immunocompetence and tumor aggressiveness in superficial bladder carcinoma.
    Decenzo JM, Leadbetter GW.
    J Urol; 1976 Mar 01; 115(3):262-3. PubMed ID: 1255884
    [Abstract] [Full Text] [Related]

  • 45. Standardization of microcytotoxicity assay for cell-mediated immunity.
    O'Toole C.
    Natl Cancer Inst Monogr; 1973 Jun 01; 37():19-24. PubMed ID: 4713781
    [No Abstract] [Full Text] [Related]

  • 46. Immunological aspects of human leukaemia.
    Viza D.
    Ser Haematol; 1972 Jun 01; 5(5):87-108. PubMed ID: 4133766
    [No Abstract] [Full Text] [Related]

  • 47. Immunity in the tumor-bearing host and its modification by serum factors.
    Baldwin RW, Embleton MJ, Price MR, Robins A.
    Cancer; 1974 Oct 01; 34(4 Suppl):suppl:1452-60. PubMed ID: 4422494
    [No Abstract] [Full Text] [Related]

  • 48. Specificity of in vitro cellular cytotoxicity against transitional cell carcinoma cell line T-24.
    Catalona WJ, Oldham RK, Djeu JY, Herberman RB, Cannon GB.
    Surg Forum; 1975 Oct 01; 26():122-4. PubMed ID: 56048
    [No Abstract] [Full Text] [Related]

  • 49. Immune response in bladder cancer.
    Merrin C, Han T.
    J Urol; 1974 Feb 01; 111(2):170-2. PubMed ID: 4810757
    [No Abstract] [Full Text] [Related]

  • 50. Evaluation of immunological reactivity in bladder cancer.
    O'Boyle PJ, Cooper EH, Williams RE.
    Br J Urol; 1974 Jun 01; 46(3):303-8. PubMed ID: 4843725
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. In vitro testing in tumor immunotherapy.
    Berkelhammer J.
    Semin Oncol; 1974 Dec 01; 1(4):397-408. PubMed ID: 4143489
    [No Abstract] [Full Text] [Related]

  • 53. Immunologic reduction of bladder cancer recurrence rate.
    Olsson CA, Chute R, Rao CN.
    J Urol; 1974 Feb 01; 111(2):173-6. PubMed ID: 4810758
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. The immunotherapy of cancer.
    Parker CW.
    Pharmacol Rev; 1973 Jun 01; 25(2):325-42. PubMed ID: 4581047
    [No Abstract] [Full Text] [Related]

  • 57. Lymphocyte-mediated immune responses in neoplasia.
    Pilch YH, Golub SH.
    Am J Clin Pathol; 1974 Aug 01; 62(2):184-211. PubMed ID: 4602086
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Urinary bladder carcinogenesis in the dog: preliminary studies on cellular immunity.
    Rippe DF, Ortiz-Muniz G, Block NL, Lynne CM, Shouger RB, Sigel MM.
    Transplant Proc; 1975 Dec 01; 7(4):495-501. PubMed ID: 1105912
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.